Actelion Pharmaceuticals, a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, has selected IntraLinks Connect to streamline its documentation exchange during clinical trials. IntraLinks Connect, a cloud-based platform, will provide central clinical trial portals to facilitate the more secure, compliant auditable exchange of site feasibility, study start-up, study conduct and study close-out documentation.
Related Analysis & Opinion
Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets
Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users